Drugs / Fluvirin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01209780 Comparator | Sep 2010 → Mar 2011 | influenza | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluvirin | “US licensed trivalent inactivated subunit influenza vaccine -Fluvirin (Novartis Vaccines and Diagnostics)” NCT01209780 ↗ |
| Known as | TIVf | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01209780 ↗ |
| Modality | Vaccine | “US licensed trivalent inactivated subunit influenza vaccine” NCT01209780 ↗ |
| Route | Intramuscular | “one or two IM dose(s) of trivalent subunit inactivated flu vaccine” NCT01209780 ↗ |